Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanqiao Ren

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|May 14, 2023
Recent advances in oncolytic virus therapy for hepatocellular carcinomaLicheng Zhu, Yu Lei, Jia Huang, et al.
Cancer Medicine|May 7, 2021
The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population-based studyLei Chen, Yanqiao Ren, Tao Sun, et al.
Journal of Hepatocellular Carcinoma|August 19, 2022
Effect of Transarterial Chemoembolization Plus Percutaneous Ethanol Injection or Radiofrequency Ablation for Liver TumorsLei Chen, Weihua Zhang, Tao Sun, et al.
Cardiovascular Diagnosis and Therapy|September 15, 2025
The effect of Angio-CT on the efficacy of hemoptysis patients with non-bronchial systemic arteries-a retrospective studyYanqiao Ren, Chao Chen, Songlin Song, et al.
Abdominal Radiology (New York)|November 25, 2021
The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombusBo Sun, Weihua Zhang, Lei Chen, et al.
Frontiers in Oncology|November 15, 2021
Superselective Transarterial Chemoembolization for Unresectable or "Ablation Unsuitable" Hepatocellular Carcinoma in the Caudate Lobe: A Real World, Single-Center Retrospective StudyLiangliang Yan, Yanqiao Ren, Kun Qian, et al.
Journal of Nanobiotechnology|April 26, 2026
Construction of ATOX1 targeted nano gel based on cuproptosis mechanism and its role in reversing TACE refractoriness of hepatocellular carcinomaChao Chen, Songlin Song, Wenlong Wu, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|March 6, 2023
Morphine prophylaxis alleviates pain in transjugular intrahepatic portosystemic shunt procedure: A randomized clinical trialLing Li, Abdala Mkangala, Zhiqi Geng, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 30, 2022
Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with DEB-TACEBin Chai, Dongqiao Xiang, Wei Wang, et al.
Frontiers in Oncology|June 22, 2021
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome and Risk Signature AnalysisYiming Liu, Yanqiao Ren, Sangluobu Ge, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|May 14, 2023
Recent advances in oncolytic virus therapy for hepatocellular carcinomaLicheng Zhu, Yu Lei, Jia Huang, et al.
Cancer Medicine|May 7, 2021
The efficacy of radiofrequency ablation versus cryoablation in the treatment of single hepatocellular carcinoma: A population-based studyLei Chen, Yanqiao Ren, Tao Sun, et al.
Journal of Hepatocellular Carcinoma|August 19, 2022
Effect of Transarterial Chemoembolization Plus Percutaneous Ethanol Injection or Radiofrequency Ablation for Liver TumorsLei Chen, Weihua Zhang, Tao Sun, et al.
Cardiovascular Diagnosis and Therapy|September 15, 2025
The effect of Angio-CT on the efficacy of hemoptysis patients with non-bronchial systemic arteries-a retrospective studyYanqiao Ren, Chao Chen, Songlin Song, et al.
Abdominal Radiology (New York)|November 25, 2021
The safety and efficacy of percutaneous ethanol injection in the treatment of tumor thrombus in advanced hepatocellular carcinoma with portal vein tumor thrombusBo Sun, Weihua Zhang, Lei Chen, et al.
Frontiers in Oncology|November 15, 2021
Superselective Transarterial Chemoembolization for Unresectable or "Ablation Unsuitable" Hepatocellular Carcinoma in the Caudate Lobe: A Real World, Single-Center Retrospective StudyLiangliang Yan, Yanqiao Ren, Kun Qian, et al.
Journal of Nanobiotechnology|April 26, 2026
Construction of ATOX1 targeted nano gel based on cuproptosis mechanism and its role in reversing TACE refractoriness of hepatocellular carcinomaChao Chen, Songlin Song, Wenlong Wu, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|March 6, 2023
Morphine prophylaxis alleviates pain in transjugular intrahepatic portosystemic shunt procedure: A randomized clinical trialLing Li, Abdala Mkangala, Zhiqi Geng, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|July 30, 2022
Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with DEB-TACEBin Chai, Dongqiao Xiang, Wei Wang, et al.
Frontiers in Oncology|June 22, 2021
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome and Risk Signature AnalysisYiming Liu, Yanqiao Ren, Sangluobu Ge, et al.
Pageof 7